Akihiko Oka Selected Research

Disease Progression

1/2022

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiko Oka Research Topics

Disease

11	Colitis 05/2022 - 02/2014
10	Inflammation (Inflammations) 01/2022 - 12/2010
8	Ulcerative Colitis 01/2024 - 01/2012
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 02/2014
6	Crohn Disease (Crohn's Disease) 01/2024 - 01/2013
3	Neoplasms (Cancer) 05/2022 - 02/2011
3	Infections 02/2021 - 01/2013
1	Carcinoma (Carcinomatosis) 06/2023
1	Anorexia Nervosa 05/2023
1	Vomiting 05/2023
1	Abdominal Pain (Pain, Abdominal) 05/2023
1	Weight Loss (Weight Reduction) 05/2023
1	Nausea 05/2023
1	Anorexia 05/2023
1	Dyspepsia (Indigestion) 05/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2022
1	Pancreatitis 05/2022
1	Ileitis 01/2022
1	Noncommunicable Diseases 01/2022
1	Disease Progression 01/2022
1	Non-alcoholic Fatty Liver Disease 03/2021
1	Body Weight (Weight, Body) 03/2021
1	Type 2 Diabetes Mellitus (MODY) 03/2021
1	Erythema elevatum diutinum 02/2021
1	Eczema 02/2021
1	Purpura 02/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2021
1	Vasculitis (Vasculitides) 02/2021
1	Proctitis 05/2019
1	Giardiasis 01/2019
1	Parasitic Diseases (Parasitic Disease) 01/2019
1	Coinfection 01/2019
1	Autoimmune enteropathy 02/2018
1	Celiac Disease (Celiac Sprue) 02/2018
1	Colonic Neoplasms (Colon Cancer) 08/2015
1	Colitis-Associated Neoplasms 08/2015
1	Carcinogenesis 08/2015
1	Amyloidosis 01/2013

Drug/Important Bio-Agent (IBA)

8	Interleukin-10 (Interleukin 10)IBA 01/2022 - 12/2010
6	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2024 - 01/2014
5	CytokinesIBA 10/2021 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2017
3	Dextrans (Dextran)FDA Link 01/2021 - 08/2015
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021 - 08/2015
2	Phosphates (Orthophosphate)IBA 01/2022 - 12/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2021
2	Infliximab (Remicade)FDA Link 02/2021 - 01/2013
2	Prednisolone (Predate)FDA LinkGeneric 01/2016 - 01/2012
2	Epidermal Growth Factor (EGF)IBA 08/2015 - 01/2012
2	milk fat globuleIBA 08/2015 - 01/2012
1	Phenobarbital (Luminal)FDA Link 06/2023
1	IS 23IBA 05/2023
1	Immune Checkpoint InhibitorsIBA 05/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022
1	NivolumabIBA 05/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2022
1	FucoseIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Ethanolamine (Colamine)IBA 01/2022
1	fuculoseIBA 01/2022
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 10/2021
1	Lipocalin-2IBA 10/2021
1	dapagliflozinIBA 03/2021
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 03/2021
1	Sodium-Glucose Transport ProteinsIBA 03/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	FructoseIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	N-acylethanolaminesIBA 01/2020
1	LipidsIBA 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	EndotoxinsIBA 01/2019
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2018
1	Immunoglobulin A (IgA)IBA 02/2018
1	Protein Glutamine gamma Glutamyltransferase 2IBA 02/2018
1	Glutens (Glutelin)IBA 02/2018
1	Serotonin (5 Hydroxytryptamine)IBA 08/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Vincristine (Oncovin)FDA LinkGeneric 01/2016
1	Rituximab (Mabthera)FDA Link 01/2016
1	R-CHOP protocolIBA 01/2016
1	AzoxymethaneIBA 08/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2014
1	DNA (Deoxyribonucleic Acid)IBA 02/2014
1	InterleukinsIBA 02/2014
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2013

Therapy/Procedure

4	Therapeutics 05/2022 - 12/2014
1	Remission Induction 05/2022
1	Phage Therapy 01/2022
1	Fecal Microbiota Transplantation 10/2021
1	Intraperitoneal Injections 08/2015
1	Blood Component Removal (Apheresis) 12/2014